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BACkGRounD: Increasing use of gastrointestinal endoscopy, particu-
larly for colorectal cancer screening, and increasing emphasis on health 
care quality, highlight the need for clearly defined, evidence-based pro-
cesses to support quality improvement in endoscopy.
oBJECtIvE: To identify processes and indicators of quality and safety 
relevant to high-quality endoscopy service delivery.
MEthoDS: A multidisciplinary group of 35 voting participants developed 
recommendation statements and performance indicators. Systematic litera-
ture searches generated 50 initial statements that were revised iteratively 
following a modified Delphi approach using a web-based evaluation and vot-
ing tool. Statement development and evidence evaluation followed the 
AGREE (Appraisal of Guidelines, REsearch and Evaluation) and GRADE 
(Grading of Recommendations, Assessment, Development and 
Evaluation) guidelines. At the consensus conference, participants voted 
anonymously on all statements using a 6-point scale. Subsequent web-
based voting evaluated recommendations for specific, individual quality 
indicators, safety indicators and mandatory endoscopy reporting fields. 
Consensus was defined a priori as agreement by 80% of participants.
RESultS: Consensus was reached on 23 recommendation statements 
addressing the following: ethics (statement 1: agreement 100%), facility 
standards and policies (statements 2 to 9: 90% to 100%), quality assurance 
(statements 10 to 13: 94% to 100%), training, education, competency and 
privileges (statements 14 to 19: 97% to 100%), endoscopy reporting stan-
dards (statements 20 and 21: 97% to 100%) and  patient perceptions 
(statements 22 and 23: 100%). Additionally, 18 quality indicators (agree-
ment 83% to 100%), 20 safety indicators (agreement 77% to 100%) and 
23 recommended endoscopy-reporting elements (agreement 91% to 
100%) were identified.
DISCuSSIon: The consensus process identified a clear need for high-
quality clinical and outcomes research to support quality improvement in 
the delivery of endoscopy services.
ConCluSIonS: The guidelines support quality improvement in endos-
copy by providing explicit recommendations on systematic monitoring, assess-
ment and modification of endoscopy service delivery to yield benefits for all 
patients affected by the practice of gastrointestinal endoscopy.
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les lignes directrices consensuelles de l'Association 
canadienne de gastroentérologie sur les indicateurs 
de sécurité et de qualité en endoscopie
hIStoRIQuE : L’utilisation croissante de l’endoscopie gastro-intestinale, 
notamment dans le cadre du dépistage du cancer colorectal, et l’accent 
grandissant mis sur la qualité des soins mettent en lumière la nécessité 
d’établir des processus probants clairement définis pour étayer l’amélioration 
de la qualité en endoscopie.
oBJECtIF : Déterminer les processus et les indicateurs de qualité et de 
sécurité pertinents pour la prestation de services d’endoscopie de qualité.
MÉthoDoloGIE : Un groupe multidisciplinaire de 35 participants 
ayant droit de vote a élaboré des énoncés de recommandations et des indi-
cateurs de rendement. Des analyses bibliographiques systématiques ont 
permis d’obtenir 50 énoncés initiaux qui ont été révisés de manière itéra-
tive conformément à la méthode Delphi modifiée au moyen d’une évalua-
tion virtuelle et d’un outil de vote. L’élaboration des énoncés et l’évaluation 
des données probantes respectaient les lignes directrices AGREE (acro-
nyme anglais d’appréciation de lignes directrices, de recherches et 
d’évaluations) et GRADE (notation de recommandations, d’appréciation, 
d’élaboration et d’évaluation). À la conférence consensuelle, les partici-
pants ont exprimé leur vote de manière anonyme à l’égard de tous les 
énoncés, au moyen d’une échelle de six points. Les votes virtuels sub-
séquents ont permis d’évaluer les recommandations relatives à des indica-
teurs de qualité spécifiques et individuels, à des indicateurs de sécurité et à 
des champs de déclaration d’endoscopie. Le consensus a été défini a priori-
par une entente entre 80 % des participants.
RÉSultAtS : Les chercheurs sont arrivés à un consensus à l’égard de 
23 énoncés de recommandation portant sur les points suivants : l’éthique 
(énoncé 1 : entente 100 %), normes et politiques de facilité (énoncés 2 à 
9 : 90 % à 100 %), assurance qualité (énoncés 10 à 13 : 94 % à 100 %), 
formation, éducation, compétence et privilèges (énoncés 14 à 19 : 97 % à 
100 %), normes de déclaration d’endoscopie (énoncés 20 et 21 : 97 % à 
100 %) et perceptions des patients (énoncés 22 et 23 : 100 %). De plus, ils 
ont repéré 18 indicateurs de qualité (entente de 83 % à 100 %), 20 indica-
teurs de sécurité (entente de 77 % à 100 %) et 23 éléments de déclaration 
d’endoscopie recommandés (entente de 91 % à 100 %).
EXPoSÉ : Le processus consensuel a permis de déterminer un besoin clair 
de recherches cliniques et d’issues de qualité pour étayer l’amélioration de 
la qualité dans la prestation des services d’endoscopie.
ConCluSIonS : Les lignes directrices appuient l’amélioration de la 
qualité en endoscopie en fournissant des recommandations explicites sur la 
surveillance, l’évaluation et la modification systématiques de la prestation 
des services d’endoscopie qui seront bénéfiques à tous les patients touchés 
par la pratique de l’endoscopie gastro-intestinale.
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Quality in digestive endoscopy has been central to the emphasis on quality care in gastroenterology worldwide. Publications, both in 
the gastroenterological and surgical literature, have primarily addressed 
issues of procedural and technical quality and of procedural and pro-
cess safety (1-8). However, recognition of the need for greater patient 
focus in health care has led to greater interest in patient access to 
procedures, in the appropriateness and timeliness of procedures, and in 
patient comfort and satisfaction.
Guidelines or position statements on various aspects of quality indi-
cators, safety indicators and credentialing for endoscopy have been 
developed by the British Society of Gastroenterology (BSG) (1), the 
American Society for Gastrointestinal Endoscopy and the American 
College of Gastroenterology (2,4), the Organisation Mondiale d’Endoscopie 
Digestive/World Organisation of Digestive Endoscopy (OMGE/OMED) 
(3), the International Agency for Research in Cancer (9) and the 
Canadian Association of Gastroenterology (CAG) (5-8). However, 
these guidelines are all procedure-based and, while they are very import-
ant, they either do not address patient needs or do not provide a frame-
work for adoption in the overall context of endoscopy services.
The Global Rating Scale (GRS) was developed from the patients’ 
perspective as a quality improvement tool relevant to the entirety of 
endoscopy service delivery (10); it was based on quality and safety 
indicators developed by the BSG (1) and was designed for the English 
National Health Service in the context of a nascent colorectal cancer 
screening program. The GRS has been credited with a marked 
improvement in the quality and availability of endoscopy services in 
England, and has been adopted in other parts of the United Kingdom. 
However, although the general principles of the GRS are broadly 
applicable, specific elements of the GRS and the associated BSG qual-
ity and safety indicators are not, necessarily, directly applicable to 
other health care systems. The development and implementation of 
endoscopy quality guidelines relevant to different jurisdictions should 
be based on the needs of the patients and the realities of clinical prac-
tice evaluated by providers and users familiar with the relevant health 
care environment.
AIMS
The primary aim in developing the present consensus guidelines was to 
identify processes and indicators relevant to the provision of high-
quality endoscopy services and to achieve consensus on broadly applic-
able standards and key indicators that will support continuing quality 
improvement for endoscopy services across many jurisdictions (1,10). 
The literature review and guideline development addressed only the 
most commonly performed endoscopic procedures: esophagogas-
troduodenoscopy and colonoscopy. However, the principal issues 
addressed in this process are also applicable to more specialized endo-
scopic procedures, although specific indicators relevant to these pro-
cedures fall beyond of the scope of the current project.
MEthoDS
Initial stages and identification of the consensus group
The guideline development process was performed in accordance with 
the Appraisal of Guidelines, REsearch and Evaluation (AGREE) 
guidelines (Figure 1) (11).
The goals of the consensus process were defined by the steering 
committee (DA, AB, RB, RC, CD, RE, CG, RH and DM) and 
endorsed by the CAG. The voting participants, invited by the steering 
committee, were selected to ensure multidisciplinary expert input from 
gastroenterologists, surgeons, nurses and administrators, as well as 
individuals with expertise in endoscopy, colorectal cancer screening, 
quality and patient safety (Appendix); two participants (MB and SF) 
joined the steering group as leads to two of the working groups. Four 
international experts (BP, PC, EK and RV) and a nonvoting moder-
ator (JM) were also invited. No patients participated; however, con-
sensus participants were provided with a summary of focus-group 
sessions conducted in a multicentre, qualitative research study that 
identified patient-derived quality indicators for endoscopy services.
Systematic literature searches
Systematic literature searches of PubMed were performed using the 
search terms: “colonoscopy”, “quality of healthcare”, “quality control”, 
“colorectal neoplasms”, “rectal neoplasms”, “adenomatous polyps”, 
“colonic polyps”, “intestinal polyps”, “digestive system neoplasms”, 
“diagnosis”, “diagnostic errors/adverse effects”, “diagnostic errors/stan-
dards”, “safety”, “mortality”, “complications” and “adverse events”. 
Searches were limited to articles published in English since 1990. Case 
reports were excluded. Additional searches (using the same search 
terms) were used to identify relevant abstracts from Digestive Disease 
Week 2007, 2008 and 2009, and United European Gastroenterology 
Week 2007 and 2008.
These searches identified 2475 articles. The citations and abstracts 
were assigned in batches to pairs of assessors from the steering commit-
tee; a dedicated, purpose-designed, online voting system was used to 
identify relevant articles on the basis of the article title and abstract. 
All conflicts were resolved by consensus. After two rounds of 
reviewing, 817 references were retained and the complete articles were 
uploaded to an online literature review site, used by the steering com-
mittee to develop draft statements. Additional literature searches were 
conducted during the statement development process, as needed.
Development of statements and iterative voting process
Fifty initial statements were developed, based on the literature review, 
analysis of the GRS and input from the steering committee; these were 
intended to be broad in nature rather than highly specific and they 
were used as a framework for continued development. An online sys-
tem enabled the 35 voting participants (Table 1) to engage in three 
rounds of votes during the development process. At each voting 
round, participants voted on the importance and content of all state-
ments using a 6-point scale (‘disagree strongly’, ‘disagree with major 
reservation’, ‘disagree with minor reservation’, ‘agree with major reser-
vation’, ‘agree with minor reservation’ and ‘agree strongly’) and com-
mented on the wording and validity of the statements. Results were 
compiled by the CAG to ensure voter anonymity.
Round 1 vote: Using the 6-point scale, participants rated the extent 
to which they agreed that each of the 50 initial statements was import-
ant and relevant to the quality or safety of endoscopy. After reviewing 
the results of this round of voting, the steering committee reduced the 
number of statements to 22 and made iterative changes to the remain-
ing statements to incorporate participants’ comments. 
Round 2 vote: Participants voted to indicate the extent of their agree-
ment with each of the 22 statements using the 6-point scale. After this 
round of voting, the 22 statements were assigned to nine working 
groups for further refinement and development of the evidence base 
before a third round of voting. The nine working groups were con-
vened to address the following topics: quality indicators, safety indica-
tors, endoscopy reporting standards, ethics, credentialing, quality 
assurance legislation, GRS development, patient perceptions of endos-
copy quality and guideline dissemination. The conclusions of the 
working groups were then reported back to the steering committee.
Round 3 vote: Participants again voted to indicate the extent of their 
agreement with each of the statements, using the 6-point scale. After 
the third round of voting, the statements were revised and two addi-
tional statements were added. The resulting 24 statements were 
reviewed by the working groups, who allocated relevant references to 
each statement to enable evidence grading.
Grading of evidence
Evidence grading was performed by two independent evaluators (GL 
and KK) using a modified Grading of Recommendation Assessment, 
Development and Evaluation (GRADE) process (Table 2) (12). This 
process involved two steps: assessment of the methodological quality 
of individual studies and assessment of the overall level of evidence 
behind each statement. Each step was performed independently by the 
two evaluators and disagreements were resolved by consensus.
The overall level of evidence across studies for each statement was 
assessed using a Summary of Findings table (13). The GRADE system 
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classifies the quality of evidence into one of four levels – high, moder-
ate, low or very low. Evidence based on randomized controlled trials 
begins as high-quality evidence, but may be decreased due to study 
limitations (identified through the risk of bias evaluation), inconsis-
tency (heterogeneity), indirectness, imprecision or other considera-
tions such as reporting bias. Evidence based on case-control or cohort 
studies starts as low-quality evidence, but may be further decreased (for 
the same reasons as for randomized controlled trials) or increased if the 
magnitude of the treatment effect is very large, if there is evidence of 
a dose-response relationship or if all plausible biases would decrease 
the magnitude of an apparent treatment effect (12). The grading was 
subsequently reviewed and approved by all consensus members.
Consensus meeting and final voting
At the three-day consensus meeting, held in June 2010, each section 
was introduced by a member of the relevant working group who sum-
marized the relevant literature and key issues. Each statement was 
subsequently discussed by the consensus group under the direction of 
the nonvoting moderator. A statement about withdrawal of consent 
was incorporated into a more general statement on consent (state-
ment 1). Thus, the final vote included 23 statements.
Following discussion, all voting participants used electronic keypads 
to record two separate anonymous votes on each statement. The first 
vote asked whether participants believed the statement should be imple-
mented, and the second asked the extent to which they agreed with the 
overall recommendation for implementation (Table 2). In voting on the 
strength of recommendation, participants were asked to consider desir-
able and undesirable effects, patient values and preferences, the quality 
of the evidence and the judicious use of resources (12).
After the meeting, voting participants used the online system to 
identify specific, individual quality indicators, safety indicators and 
mandatory endoscopy reporting fields that they would recommend, 
again using a six-point scale for each item: ‘disagree strongly’, ‘disagree 
moderately’, ‘disagree slightly’, ‘agree slightly’, ‘agree moderately’ and 
‘agree strongly’.
For each vote, a recommendation was considered to have been 
adopted by consensus if 80% or more of participants selected ‘agree 
slightly’, ‘agree moderately’ or ‘agree strongly’.
Ethics and financial support
The consensus process and meeting were administered by the CAG, 
supported by Canadian Partnership Against Cancer/Partenariat 
Canadien Contre le Cancer and Canadian Institutes of Health Research/
Instituts de Recherche en Santé du Canada: Institute of Nutrition, 
Metabolism, and Diabetes. All members provided conflict of interest 
statements before the meeting. Honoraria for participation were pro-
vided for international experts and participants who were not mem-
bers of the CAG. Travel and accommodation were provided for all 
participants. After review of all disclosures, it was determined that 
there should be no limitations placed on any participant (14).
TAble 2
Categorization of evidence, classification of 
recommendations and voting options
Grade of evidence
High: Further research is very unlikely to change our confidence in the  
estimate of effect
Moderate: Further research is likely to have an important impact on our  
confidence in the estimate of effect and may change the estimate
Low: Further research is very likely to have an important impact on our  
confidence in the estimate of effect and is likely to change the estimate
Very low: Any estimate of effect is very uncertain
Category of recommendation
“Do it” or “don’t do it”: Indicates a judgment that most well-informed people 
would make
“Probably do it” or “probably don’t do it”: Indicates a judgment that the 
majority of well-informed people would make but a substantial minority 
would not
First vote – should this statement be implemented?
Strong recommendation in favour – do it
Weak recommendation in favour – possibly do it
Weak recommendation against – possibly don’t do it
Strong recommendation against – don’t do it
Second vote – how much do you agree with the overall 
recommendation for implementation?
Agree strongly
Agree moderately
Agree slightly
Disagree slightly
Disagree moderately
Disagree strongly
Ini�a�on of process and iden�fica�on of steering commi�ee 
First steering commi�ee mee�ng 
Development of ini�al statements 
Ini�al 50 statements sent to all members 
for first round of vo�ng 
Revised 22 statements sent to all members 
for second round of vo�ng 
First revision of statements by steering group 
Consensus mee�ng: 24 statements presented to all 
members for final round of vo�ng in person 
Second revision of statements by steering group 
Statements finalized and manuscript prepared 
Figure 1) Guideline development process
TAble 1
Details of participants participating in the final round of 
voting (n=35)
Specialty
Gastroenterology 28 (80)
Surgery 3 (8.6)
Endoscopy nurse 1 (2.9)
Other 3 (8.6)
Country of employment
Canada 32 (91.4)
Other 3 (8.6)
Endoscopic practice
Perform upper endoscopy 31 (88.6)
Perform colonoscopy 30 (85.7)
Perform ERCP or other advanced procedures 17 (48.6)
Location of endoscopic practice
Academic health centre 23 (65.7)
Hospital setting 31 (88.6)
Out-of-hospital facility 12 (34.3)
Data presented as n (%). ERCP Endoscopic retrograde cholangiopancre-
atography
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ConSEnSuS StAtEMEntS
SECtIon 1: EthICS
Introduction
Informed consent must be obtained from a patient before any endo-
scopic procedure is performed. This statement provides the legal and 
ethical background to this position.
Statement 1. For a patient to give a physician informed consent 
to perform an elective endoscopic procedure, the patient must be 
advised, in a timely fashion, of all relevant information about the 
procedure, its risks, benefits and alternatives, if any, and be given 
an opportunity to ask questions that the physician must answer. 
Evidence grade: Low/very low
Strength of recommendation: Do it, 91%; possibly do it, 6%; 
possibly don’t do it, 3%
level of agreement with recommendation: Agree, 100% (agree 
strongly, 65%; agree moderately, 29%; agree slightly, 6%)
Discussion
This statement describes the minimum required to document accept-
able provision of informed consent, consistent with Canadian law. It is 
necessary to obtain informed consent in a way that satisfies the 
patient’s expectation of full, informed consent based on individual 
needs for information to address personal concerns. The patient can be 
provided with information or instructions (eg, for bowel preparation) 
in several formats, including videotapes (15-17), brochures, informa-
tion sessions led by allied health care professionals (nurses or assist-
ants) or computer-assisted instructions/interactive software (18). 
However, these forms of communication do not obviate the need for a 
conversation with the endoscopist; it is the endoscopist who should 
obtain informed consent. Trainees may obtain consent if they are to 
perform the procedure and if disclosure is complete. However, in one 
study, up to one-third of trainees obtaining consent for colonoscopy 
had not disclosed the risks of perforation and hemorrhage (19). 
Ultimately, it is the supervisor who is responsible for ensuring that 
complete information is provided and that questions have been appro-
priately answered.
For an elective procedure, disclosure should allow the patient suf-
ficient time to understand the information, reflect on it, ask questions 
and decide whether to proceed or to select an alternative. In an emer-
gency situation, informed consent should be obtained as soon as pos-
sible. For direct-access endoscopy, the patient may be sent information 
before the procedure, although, in one study, 37% of patients would 
have preferred meeting a gastroenterologist before the colonoscopy 
and 20% said that they received the most useful information after tak-
ing the bowel preparation (20). In all cases, full verbal disclosure, 
documented in the patient record, is still required before the procedure 
(Box 1).
box 1
Full disclosure for informed consent:  
Required elements for review
•	Indication	for	the	procedure
•	Nature	of	the	procedure
•	Need	for	preparation
 Risks and benefits of preparation
 Alternative preparations
•	Patients’	concerns	about	discomfort	and	pain
•	Benefits	and	limitations	of	the	procedure
 Full disclosure of risks
▪	Procedure-specific	risks	(eg,	bleeding,	perforation,	need	for	surgery	or	
stoma	to	manage	complications)	(21,22)
▪	Risks	of	missed	lesions	(23)
▪	Risks	of	sedation,	if	administered	(24,25)
•	Alternatives	to	the	procedure
 Option of no investigations or treatment
 Potential alternative therapies including risks and benefits
•	Sedation	options
	Risks,	benefits	and	adverse	events	of	all	options
▪	No	sedation
▪	Conscious	sedation	and	deep	sedation/general	anesthesia
▪	Alternatives	including	hypnotic	relaxation,	music,	electro-acupuncture	
and	nitrous	oxide
The choice of sedation (or no sedation) should be a shared deci-
sion, made on a case-by-case basis, between the attending physician/
endoscopist and patient, based on the patient’s expectations of com-
fort, the patient’s medical condition, and complexity and duration of 
the procedure. Regardless of the type of sedation recommended, 
patients should understand that they may decline sedation.
The consent process should account for the patient’s competence 
and understanding. Language, cognitive ability, severity of illness, pain 
and analgesia may affect a patient’s capacity to understand and con-
sent to a procedure. Provision of informed consent is not a guarantee 
that the patient has understood the information provided; recall of 
informed consent is often suboptimal. In one study, 50% of patients 
could not recall important information on their procedure’s indication 
or risks or when consent was obtained (26). Effort should be made to 
ensure that the patient has the capacity to consent and to maximize 
their understanding of the information provided, possibly by comple-
menting oral with written information.
Consent must be given without coercion; this implies that consent 
can be withdrawn at any time. However, it is possible that a patient 
under sedation may not be fully cognizant of their request to halt a 
procedure and the associated risks; nonetheless, if a patient requests 
that the procedure be stopped, the endoscopist should review his or 
her technique, the patient’s comfort and the need to continue. 
Procedure cessation may put the patient at risk of increased complica-
tions and may not be appropriate.
SECtIon 2: FACIlIty StAnDARDS AnD PolICIES
Introduction
Endoscopy facilities must meet or exceed defined standards of quality 
for operating standards, appropriateness of procedure, and technical 
and personnel resources. Facilities also must have policies in place that 
ensure best practice before, during and after endoscopic procedures.
Statement 2. Endoscopy facilities should meet or exceed defined 
operating standards, in all domains, consistent with accreditation 
under the appropriate national or regional standards.
Evidence grade: Low/very low
Strength of recommendation: Do it, 91%; possibly do it, 6%; don’t 
do it, 3%
level of agreement with recommendation: Agree, 97% (agree 
strongly, 85%; agree moderately, 12%; disagree slightly, 3%)
Discussion
Operating standards may be endorsed locally by many endoscopists 
and endoscopy facilities, but adoption of appropriate standards is not 
universal and approved; accepted national guidelines are unavailable 
in many jurisdictions. Although endoscopic facilities differ greatly 
with respect to structure, size and procedural case loads, operating 
standards should apply uniformly, regardless of the facility’s size, design 
or location. It is, however, recognized that standards may be achieved 
by different means in different facilities.
In many jurisdictions, accrediting bodies do not have specific dir-
ectives for endoscopy facilities. If endoscopy facilities are to be 
included in hospital accreditation programs, comprehensive directives 
must be specified to ensure that high-quality care becomes 
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the standard. Ideally, accreditation of hospital and out-of-hospital 
endoscopy facilities should be governed by comparable processes to 
support continuous quality improvement programs, with regular 
review in all cases.
The adoption of standards and procedures to ensure safety and 
quality should also support appropriate resource use; indicators of 
appropriate utilization include no-show rates, adequacy of prepara-
tion, nurse-to-patient ratios, safe working environment and appropri-
ate flow of patients. Quality assurance activities should be defined 
from a patient perspective, and should target indicators of procedural 
completeness and accuracy, opportunities for patient feedback, and 
evidence of continued change and reassessment to demonstrate 
improvement (see section 3 below). Quality and safety standards 
should also address endoscope reprocessing, conscious sedation, mon-
itoring protocols and resuscitation equipment. Although documented 
transmission of infection from endoscopic equipment is extremely 
rare (27), the United States Food and Drug Administration recom-
mends that all institutions have a written program and appropriate 
administrative organization for endoscope processing, handling and 
storage (28). Every facility providing endoscopic services should 
ensure the ongoing availability of protocols, equipment, and trained, 
competent personnel necessary for the provision of safe and effective 
conscious sedation.
Statement 3. Endoscopic procedures are performed for an 
appropriate, clearly documented indication, consistent with 
current, evidence-based guidelines.
Evidence grade: Low/very low
Strength of recommendation: Do it, 97%; possibly don’t do it, 3%
level of agreement with recommendation: Agree, 97% (agree 
strongly, 85%; agree moderately, 6%; agree slightly, 6%; disagree 
slightly, 3%)
Discussion
The indication for every procedure should be documented in the pro-
cedure report, and the indication should be consistent with accepted 
guidelines. National or regional guidelines are preferable; however, if 
none are available or applicable, locally relevant guidelines should be 
developed.
Consensus guidelines provide explicit statements of appropriate 
indications for endoscopic procedures (29,30), and there is evidence 
that the diagnostic yield of endoscopy is significantly increased if pro-
cedures are performed for appropriate indications (31,32). Regrettably, 
reports indicate that 11% to 39% of endoscopic procedures are per-
formed for inappropriate indications (31,33), and that surveillance 
endoscopies may be performed at inappropriate intervals (34) or 
unnecessarily (35-37). However, guidelines should not be the only 
determinants of procedural appropriateness; for example, esophagas-
troduodenoscopy may be an inappropriate initial step in dyspepsia 
management, but it may become appropriate if initial medical therapy 
fails (29). Similarly, a colonoscopic surveillance interval may, appropri-
ately, be shorter than recommended if, for example, bowel preparation is 
poor. However, in all cases, the reason for deviation from guidelines or 
accepted indications should be clearly documented.
Statement 4. Endoscopy facilities should have the technical and 
personnel resources required by national and/or regional standards 
to complete all planned procedures safely and effectively.
Evidence grade: Low/very low
Strength of recommendation: Do it, 91%; possibly do it, 6%; pos-
sibly don’t do it, 3%
level of agreement with recommendation: Agree, 100% (agree 
strongly, 69%; agree moderately, 26%; agree slightly, 6%)
Discussion
Published, evidence-based guidelines do, on occasion, specify the 
technical and personnel resources needed for procedures, such as 
endoscopic reprocessing and urgent endoscopy, in the event of a major 
gastrointestinal bleed (28,38). The importance of experienced ancil-
lary personnel for procedural quality and efficiency is highlighted, for 
example, by reports of higher polyp detections rates at screening 
colonoscopy in the presence of more experienced nurses (detection 
rate of 46% with more than six months of experience versus 40% with 
six months or less; OR 1.26 [95% CI 1.09 to 1.46]) (39) or of efficiency 
gains of up to 30% when additional personnel were available to gain 
intravenous access and administer medications (40).
A skills mix review (41) can identify the personnel resources 
necessary for a particular institution or facility, based on types of pro-
cedures performed, types of sedation offered and need for out-of-hours 
emergency services.
Statement 5. Endoscopy facilities should implement and monitor 
the effect of preprocedure policies that ensure best practice.
Evidence grade: Low/very low
Strength of recommendation: Do it, 97%; possibly don’t do it, 3%
level of agreement with recommendation: Agree, 97% (agree 
strongly, 86%; agree moderately, 9%; agree slightly, 3%; disagree 
slightly, 3%)
Discussion
Preprocedure assessment should encompass the risks of sedation, the 
preparation and the procedure, including documented assessments of 
patient age, comorbidity, American Society of Anesthesiologists clas-
sification, significant medical issues, medications (including type of 
bowel preparation) and potential complications of bowel preparation 
(such as dehydration). Relevant policies and guidelines should be 
implemented (Box 2).
box 2
Preprocedure guidelines that should be implemented
•	Antibiotic	prophylaxis	guidelines	for	prevention	of	infective	endocarditis;	
eg,	American	Heart	Association	(42)	and	BSG	guidelines	(43).
•	Antithrombotic	agent	guidelines	on	management	of	antithrombotic	agents	
for	endoscopic	procedures;	eg,	American	Society	for	Gastrointestinal	
Endoscopy	guidelines	(44)	state	that	anticoagulant	agents	(eg,	warfarin,	
unfractionated	heparin,	low-molecular-weight	heparin)	and	antiplatelet	
agents	(eg,	acetylsalicylic	acid,	clopidogrel,	ticlopidine,	glycoprotein	IIb/
IIIa receptor inhibitors) increase the risks of procedure-related bleeding. 
Preprocedural	assessment	should	encompass	the	benefits,	risks	and	
urgency	of	the	procedure,	the	bleeding	risks	associated	with	
antithrombotic	therapy	and	the	procedure,	and	the	thromboembolic	risk	
of stopping therapy.
•	Surveillance	schedules	(eg,	Barrett’s	esophagus,	ulcerative	colitis)
•	Diabetes	mellitus	management	guidelines	(45,46)
•	Anesthetic/sedation	risk	guidelines	(47)
•	Allergy	or	drug	sensitivity	guidelines	(48)
•	Procedural	pause	(48)
Statement 6. Endoscopy facilities should implement and monitor 
the effect of intraprocedural policies that ensure best practice.
Evidence grade: Low/very low
Strength of recommendation: Do it, 94%; possibly do it, 3%; pos-
sibly don’t do it, 3%
level of agreement with recommendation: Agree, 97% (agree 
strongly, 85%; agree moderately, 9%; agree slightly, 3%; disagree 
moderately, 3%)
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Discussion
Intraprocedural policies are important to achieve and maintain max-
imal patient safety and comfort and optimal examination quality (Box 3). 
Completion of colonoscopy, with complete cecal visualization, is 
essential for detecting lesions in the proximal colon. Endoscopists with 
a higher cecal intubation rate have a higher rate of colonic neoplastic 
lesion detection (49). Documentation of cecal intubation using still 
image or, preferably, video recording (50) of the appendiceal orifice 
and ileocecal valve, should be confirmed by the endoscopy assistant/
nurse. Terminal ileum biopsy should be performed only if indicated 
clinically. Right iliac fossa transillumination and finger indentation 
are inadequate to confirm cecal intubation (51). Cecal intubation 
rates greater than 90%, documented in several case series (52-54), 
should be standard of practice for symptomatic patients and intubation 
rates should exceed 95% for screening colonoscopies (1,3).
Conscious sedation (intravenous benzodiazepines, with or without 
narcotics, or propofol) may improve endoscopy completion rates (55) 
but is resource intensive. An evidence-based sedation protocol can 
improve practice quality and reduce sedation-related adverse events 
(56,57).
Poor bowel preparation is associated with longer procedure time 
(58), greater patient discomfort (58), lower colonoscopy completion 
rates (55), and higher risks of adverse events and missed lesions. A 
standardized tool such as the Ottawa Bowel Preparation scale (59) or 
the Boston Bowel Preparation scale (60) should be used to assess bowel 
preparation quality and process changes should be implemented if 
inadequate bowel preparation is prevalent.
Endoscopy facilities should institute a policy to record the colonos-
copy withdrawal time as a surrogate for a thorough examination. 
Longer withdrawal times are associated with greater detection rates for 
advanced neoplasia (adenomata of 10 mm or larger, lesions with vil-
lous change, high-grade dysplasia or cancer) (61) and advanced neo-
plasia detection is improved by a protocol specifying a minimum 
withdrawal time of 8 min (62).
box 3
Intraprocedural policies that should be implemented
•	Verified,	objective	photo	or	video	documentation	of	cecal	intubation
•	Regular	monitoring	of	sedation	level	(eg,	implementation	of	an	evidence-
based sedation protocol)
•	Regular	monitoring	of	relevant	physiological	parameters	(blood	pressure,	
pulse,	oxygen	saturation,	etc)
•	Routine	evaluation	of	bowel	preparation	(ie,	a	standardized	tool	such	as	
the	Ottawa	Bowel	Preparation	scale	[59]	or	the	Boston	Bowel	Preparation	
scale	[60])
•	Documentation	of	withdrawal	time	during	colonoscopy	–	a	minimum	of	
8	min	is	ideal	(withdrawal	time	is	correlated	with	a	thorough	examination)
•	Regular	monitoring	of	patient	comfort
•	Dual	observation	during	examination	(endoscopist	and	nurse)
Statement 7. the endoscopy facility should implement and 
monitor the effects of policies for the discharge of patients that 
ensure best practice.
Evidence grade: Very low
Strength of recommendation: Do it, 97%; possibly do it, 3%
level of agreement with recommendation: Agree, 100% (agree 
strongly, 89%; agree moderately, 9%; agree slightly, 3%)
Discussion
Clear specific discharge policies (Box 4), should be implemented 
and should accommodate differences in patients’ responses, particu-
larly, to sedation. Elderly patients (70 years of age and older) and 
those with oxygen desaturation, hypotension, bradycardia and those 
needing reversal agents require longer recovery times (63). A list 
of criteria such as the Aldrete score (respiration, oxygen saturation, 
consciousness, circulation and activity levels) should be used to deter-
mine readiness for discharge (64,65). The half-life of reversal agents 
tends to be shorter than the half-life of sedatives; therefore, reversal 
agent effects may wane before those of the sedative. Discharge poli-
cies should specify patient transportation requirements and activity 
restrictions after the procedure, with respect to the type and dose of 
sedation.
Patient satisfaction with discharge processes should be assessed 
regularly, for example, using standardized postdischarge surveys.
box 4 
Policies for discharge of patients that should be 
implemented
•	Standard	criteria	(eg,	Aldrete	score	[64,65])	to	determine	readiness	for	 
discharge
•	Result	of	discharge	tool	entered	on	the	patient’s	record
•	Regular	monitoring	of	patient	satisfaction	with	discharge	process
•	Standards	for	24	h	activity	restrictions	for	patients	who	receive	sedation
Statement 8. Endoscopy facilities should ensure that there is a policy 
in place to notify patients of the need, and appropriate interval, for 
follow-up.
Evidence grade: Low/very low
Strength of recommendation: Do it, 76%; possibly do it, 18%; pos-
sibly don’t do it, 3%; don’t do it, 3%
level of agreement with recommendation: Agree, 90% (agree 
strongly, 39%; agree moderately, 42%; agree slightly, 9%; disagree 
slightly, 6%; disagree moderately, 3%)
Statement 9. All patients, on discharge, are given written informa-
tion regarding the procedural findings, plans for treatment and 
follow-up, worrisome symptoms to watch for, and steps to be 
taken.
Evidence grade: Very low
Strength of recommendation: Do it, 97%; possibly do it, 3%
level of agreement with recommendation: Agree, 100% (agree 
strongly, 86%; agree moderately, 6%; agree slightly, 9%)
Discussion
On discharge, written details of the procedure should be provided for the 
information of the patient and of any physician providing subsequent care 
(eg, for complications). Provision of a procedure report reduced patients’ 
postprocedure anxiety, improved their recall of findings and recommenda-
tions and improved adherence to recommendations (66).
The facility’s policies should specify the information to be provided in 
the discharge report (Box 5), the details of follow-up arrangements 
that have been or will be made and the person responsible for arran-
ging the follow-up plan.
box 5
Discharge report – key elements
•	Description	of	key	findings,	interventions,	complications	and	sedation
•	Description	of	symptoms	of	potential	complications
•	Instructions	on	actions	to	be	taken	if	symptoms	of	complications	arise
•	Contact	details	in	the	event	that	complications	arise
•	Instructions	on	resumption	of	anticoagulants
•	Instructions	for	follow-up	(why,	when,	where	and	with	whom)
SECtIon 3: QuAlIty ASSuRAnCE
Introduction
Maintaining and enhancing the quality and safety of endoscopy servi-
ces should be a continuous process that measures aspects of endoscopic 
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performance, implements changes based on these measurements, mon-
itors the effect of these changes and evaluates these effects to achieve 
new standards (Figure 2).
Statement 10. Endoscopy facilities should maintain a comprehen-
sive quality improvement program incorporating formal, regular, 
scheduled review of performance reports.
Evidence grade: Low/very low
Strength of recommendation: Do it, 85%; possibly do it, 9%; pos-
sibly don’t do it, 3%; don’t do it, 3%
level of agreement with recommendation: Agree, 94% (agree 
strongly, 76%; agree moderately, 12%; agree slightly, 6%; disagree 
slightly, 6%)
Statement 11. Endoscopy facilities should appoint a review 
committee to monitor and report back to management on 
adherence to and implementation of quality standards.
Evidence grade: Low/very low
Strength of recommendation: Do it, 79%; possibly do it, 21%
level of agreement with recommendation: Agree, 97% (agree 
strongly, 71%; agree moderately, 24%; agree slightly, 3%; disagree 
strongly, 3%)
Discussion
In some jurisdictions, quality assurance activities are legislated and, 
in many jurisdictions, a quality assurance committee’s proceedings 
are protected from disclosure if it is constituted according to applic-
able regional, territorial, state or national legislation and regula-
tions (66-77). Thus, endoscopy quality assurance committees must 
be developed within the appropriate legislative framework to over-
see the performance of the endoscopy facility and all of its person-
nel. The potential conflicts arising from the disparate perspectives 
of different stakeholders can be resolved if quality in endoscopy is 
addressed from the perspective of the patient. In developing the 
GRS for evaluation of endoscopy, two patient-centred quality 
dimensions were devised (10): the “Clinical Quality and Safety” 
dimension addressed six items related to appropriateness of the 
procedure, information and consent, safety, patient comfort, qual-
ity and prompt communication of results, while the “Quality of 
Patient Experience” (customer care) dimension addressed six items 
related to equality, timeliness, patient choice, privacy and dignity, 
aftercare and the ability to provide feedback to the endoscopy 
service.
A quality improvement and assessment tool such as the 
GRS provides a framework to support evaluation of service 
delivery by identifying specific indicators, consistent with 
high-quality endoscopy that should be auditable (ie, relevant 
outcomes for which there are no set standards) or measurable 
(ie, relevant outcomes for which there is an established 
standard).
Statement 12. Endoscopy facilities should systematically and 
regularly review current indicators of quality for all endoscopic 
procedures and implement appropriate responses.
Evidence grade: Low/very low
Strength of recommendation: Do it, 88%; possibly do it, 9%; don’t 
do it, 3%
level of agreement with recommendation: Agree, 97% (agree 
strongly, 88%; agree moderately, 9%; disagree strongly, 3%)
Statement 13. Endoscopy facilities should systematically and 
regularly review current indicators of safety for all endoscopic 
procedures and implement appropriate responses.
Evidence grade: Low/very low
Strength of recommendation: Do it, 91%; possibly do it, 9%
level of agreement with recommendation: Agree, 100% (agree 
strongly, 82%; agree moderately, 15%; agree slightly, 3%)
Discussion
Quality indicators and safety indicators for endoscopy were considered 
sufficiently distinct that two working groups were charged with identi-
fying measurable or auditable outcomes that would support quality 
improvement. After the consensus meeting, participants voted on 
their endorsement of each quality and safety indicator identified by 
the working groups (Boxes 6 and 7).
box 6
Indicators of quality in endoscopy
Indicator  
Comment
Consensus,  
%
Indicator related to entire endoscopy facility
1.	Participation	in	a	recognized	quality	assurance	program 97.2
Indicators related to the technical performance of the procedure and 
appropriateness
2. Completion of procedure 100.0
	 Documented	inspection	of	duodenum,	cecum	or	terminal	
ileum
3. Appropriateness of procedure 97.2
 Performed for an appropriate indication
4. Completeness of procedure 97.2
	 Inspection	of	all	relevant	areas,	acquisition	of	
appropriate biopsies and completion of all appropriate 
interventions
5. Withdrawal time 85.6
	 As	a	minimum,	rapid	withdrawal	precludes	complete	
inspection;	especially	colonoscopy
6. Adenoma detection rate 100.0
	 Requires	reconciliation	of	pathology	and	endoscopy	
reports
7. Polyp detection rate 91.4
	 A	surrogate	marker	for	a	careful	examination
8. Appropriateness of endoscopic intervention 97.2
	 Interventions	are	performed,	or	eschewed,	appropriately,	
according to the indication and findings
9. Completion of endoscopic intervention 97.2
Standard Define outcomes 
Measure 
outcomes 
Monitor impact 
of changes 
Implement 
changes 
Feedback 
results 
Continuous 
quality 
improvement 
Figure 2) Continuous process of quality improvement
Continued on next page
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	 Interventions	are	performed	to	completion	(eg,	
polypectomy)
10. Appropriateness of biopsy 94.3
	 Biopsies	are	performed,	or	eschewed,	appropriately,	
according to the indication and findings
Patient-centred indicators of quality
11.	Quality	of	patient	experience 97.2
 There is a formal assessment of the patient’s 
experience,	preferably	using	a	standard	tool
12. Sedation dosage 82.8
	 Systematic	overuse	or	underuse	of	sedation	is	identified;	
usage is correlated with outcome
Indicators relevant to quality of preparation before procedure
13. Quality of bowel preparation 97.2
	 Assessed	formally,	using	a	validated	tool	or,	at	a	
minimum,	a	standard	scale	(eg,	poor,	fair,	good)
14. Appropriateness of antithrombotic management 91.4
 Consistent with accepted guidelines
15.	Appropriateness	of	antibiotic	prophylaxis	management 82.8
 Consistent with accepted guidelines
Indicator relevant to quality of communication regarding results
16. Completion of endoscopy reporting 97.2
	 Procedure	results	report	should	be	complete,	with	all	
relevant	information	included,	and	should	be	available	
immediately
Indicator of procedural quality relevant, predominantly, to colonoscopy 
screening and surveillance programs
17. Interval cancer incidence 97.2
	 Requires	reconciliation	of	endoscopy	report	and	health	
records
Indicator of technical competence related, predominantly, to the  
endoscopist
18. Number of procedures performed annually 97.2
 A marker for maintenance of competence
Quality and safety indicators should be recorded systematically; the 
American College of Surgeons National Surgical Quality Improvement 
Program (78) is a potential model for a safety monitoring system, 
although it is labour intensive and would require modification for use 
in endoscopy.
box 7
Indicators of safety compromise in endoscopy
Indicator  
Comment
Consensus, 
%
Indicators of increased risk of complications
1. Use of reversal agents 88.6
 An indication of inappropriate sedation practice
2. Sedation doses in patients older than 70 years 82.8
 Evaluation of sedation use in susceptible patients who 
have greater risk of comorbidities
Indicators related to an increased risk of immediate complications
3. Need for cardiopulmonary resuscitation 97.2
 For any cause – with assessment of causal relationship
4. Allergic reactions 80.0
 For documented or undocumented allergens
5. Laryngospasm or bronchospasm 80.0
 For any cause – with assessment of causal relationship
6.	Hypoxia	(oxygen	saturation	<85%) 88.6
 For any cause – with assessment of causal relationship
7.	Hypotension:	<90/50	mmHg	or	fall	of	≥20%	from	baseline	
For any cause – with assessment of causal relationship
88.6
8.	Hypertension:	>190/130	mmHg	or	rise	of	≥20%	from	
baseline
80.0
 For any cause – with assessment of causal relationship
9. Symptomatic metabolic complications 80.0
	 Symptomatic	hypoglycemia	or	hyperglycemia;	
symptomatic	disturbance	of	fluid	and/or	electrolyte	status	
10. Perforation 100.0
 Occurring during or after procedure
11. Immediate postpolypectomy bleeding 94.3
 This may have been treated successfully during the 
procedure	or	it	may	be	persistent	and/or	requiring	
transfusion
12. Severe persistent abdominal pain 91.4
	 Requiring	further	evaluation	but	not	proven	as	perforation
13. Impaction of instrument 94.3
	 Includes	therapeutic	accessories,	eg,	snare	or	basket
14. Instrument malfunction 77.1
	 Includes	endoscope,	accessories	or	ancillary	equipment	
(eg,	processor,	monitor,	lighting,	computer,	etc)
15. Admission or transfer to an emergency department 94.3
 Includes transfer from endoscopy unit for any reason 
other than the underlying gastrointestinal condition
Indicators related to an increased risk of late complications
16. Infection 88.6
	 Including	acute	(eg,	Clostridium difficile,	abscess,	
endocarditis)	and	chronic	(eg,	hepatitis	C)	infections;	
presentation may be early or delayed
17. Gastrointestinal bleeding within 14 days of the procedure 88.6
	 Upper	or	lower	gastrointestinal	origin:	eg,	postpolypectomy	
or postbiopsy
18.	Unplanned	hospitalization	within	14	days	of	the	procedure	
For any cause – with assessment of causal relationship
94.3
19. Unplanned contact with health care provider within  
14 days of the procedure
91.4
	 For	any	reason	–	eg,	for	abdominal	pain	or	infection	–	
with assessment of causal relationship
20. Death within 30 days 94.3
 For any reason – with assessment of causal relationship 
and evaluation of mortality attributable to the underlying 
gastrointestinal condition
Adverse events should be reviewed by the facility’s endoscopy 
quality review committee to determine the indication for the proced-
ure and decision as to the level of attribution (eg, definitely, probably, 
possibly or unlikely to be due to the procedure), as recommended for 
good clinical practice in clinical research (79), the severity of the 
event and the appropriateness of the procedure. Changes should be 
implemented as appropriate and the impact of changes made should be 
reviewed within an acceptable time frame (such as three to six 
months).
Indicators of safety compromise may be monitored by phone call 
follow-up, questionnaire mail back or review of hospital admissions. 
At a minimum, relevant clinical events and near misses should be 
recorded, systematically, through a safety learning report system to 
identify risks, reduce the likelihood of complications, improve safety of 
the service and reassure patients and physicians.
SECtIon 4: tRAInInG, EDuCAtIon, CoMPEtEnCy 
AnD PRIvIlEGES
Introduction
To provide high-quality endoscopy services, endoscopy staff ’s skills 
must meet predefined standards. This requires that endoscopy facilities 
provide staff with the opportunities to evaluate, maintain and improve 
their skills on a regular basis while accommodating the disparate needs 
of patients, trainees, trainers and the facility.
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Statement 14. Endoscopy facilities should provide high-quality 
education programs or opportunities for all staff.
Evidence grade: Very low
Strength of recommendation: Do it, 86%; possibly do it, 14%
level of agreement with recommendation: Agree, 100% (agree 
strongly, 66%; agree moderately, 26%; agree slightly, 9%)
Discussion
Endoscopy facilities should provide continuing training and compe-
tency assessment for all staff in all their areas of activities, including 
clinical policies, patient monitoring, administration of intravenous 
medications, endoscope handling and maintenance, use of accessories, 
emergency procedures, decontamination, patient recovery, communi-
cation skills and new technologies. The benefits of nurse training, for 
example, include improved polyp detection rates (39) and non-
pharmacological management of pain and anxiety.
This statement does not imply that the facility should pay for all 
education opportunities or support ‘growth opportunities’ that are not 
congruent with the facility’s needs. It does, however, imply that all 
staff members have the opportunity to evaluate and maintain skills 
relevant to their position.
Statement 15. All endoscopy facility personnel in training 
should be supervised and their performance monitored regularly 
until they have achieved competency to perform specified 
routine and/or emergency procedures according to appropriate 
current standards.
Evidence grade: Low/very low
Strength of recommendation: Do it, 97%; possibly do it, 3%
level of agreement with recommendation: Agree, 100% (agree 
strongly, 94%; agree moderately, 3%; agree slightly, 3%)
Statement 16. All endoscopy facility personnel engaged, directly 
or indirectly, in endoscopy service delivery should be trained and 
certified as having competency to perform specified routine and/
or emergency procedures according to appropriate current 
standards.
Evidence grade: Low/very low
Strength of recommendation: Do it, 97%; possibly do it, 3%
level of agreement with recommendation: Agree, 97% (agree 
strongly, 91%; agree moderately, 6%; disagree strongly, 3%)
Discussion
Competency is the minimal level of skill, knowledge and expertise 
derived through training and experience required to perform a task or 
procedure safely and proficiently, without assistance or supervision 
(80). Endoscopists must be competent to perform endoscopic proced-
ures safely and to interpret and manage findings correctly. Competency 
for specific procedures should be assessed by objective measures with 
full documentation of the number and type of procedures performed. 
Methods for determining competency should include guidelines on 
the role of observers, number of cases observed and criteria assessed. 
Competency assessment should encompass proficiency in common 
therapeutic interventions, cognitive competency (ie, how to manage 
the patient overall) and technical competency.
Minimal levels of endoscopic competency should be defined, con-
sistent with the OMGE/OMED guidelines on credentialing and quality 
assurance in digestive endoscopy (Box 8) (3). The minimum numbers 
of procedures recommended by many professional associations as 
thresholds for evaluation of competency, may be markedly lower than 
numbers required for documentation of proficiency (81,82).
box 8
Competencies required by end of training (oMGe/oMeD) (3)
•	Successful	completion	of	a	recognized	medical	or	surgical	training	program
•	Ability	to	integrate	endoscopy	into	the	clinical	management	plan	(be	this	
medical,	surgical	or	referral	for	specialty	services)
•	Understanding	of	indications,	contraindications	and	risks	related	to	
procedures
•	Ability	to	clearly	describe	to	the	patient,	in	layman’s	terms,	details	of	the	
procedure	including	attendant	risks	and,	thus,	to	obtain	informed	consent
•	Sound	knowledge	of	endoscopic	anatomy
•	Familiarity	with	the	technical	and	safety	features	of	the	endoscope	and	
accessories and an understanding of proper endoscope reprocessing and 
infection control
•	Ability	to	accurately	identify	and	interpret	endoscopic	findings
•	Understanding	of	pharmacology,	administration	and	risks	of	sedation/
analgesia
•	Ability	to	perform	procedures	competently,	including	common	methods	for	
tissue sampling and therapy
•	Ability	to	diagnose	and	manage	complications	promptly	and	competently
•	Ability	to	recognize	limitations	of	endoscopic	technology	and	of	their	own	
skill in management or therapy of endoscopic findings
•	Ability	to	document	findings	and	communicate	them	with	patients	and	other	
health care providers
•	Ability	to	maintain	a	record	of	key	performance	indicators
Statement 17. Endoscopists should regularly review their endo-
scopic practice and outcome data with the aim of continuous 
professional development.
Evidence grade: Low, very low
Strength of recommendation: Do it, 94%; possibly do it, 6%
level of agreement with recommendation: Agree, 97% (agree 
strongly, 66%; agree moderately, 29%; agree slightly, 3%; disagree 
slightly, 3%)
Discussion
Under the auspices of a properly constituted quality assurance committee 
(see statements 10 and 11) (66-77), endoscopists should review their 
endoscopy practice data regularly including the number and type of 
procedures, and standard quality and safety indicator outcomes (eg, 
completion rates, unplanned events, comfort scores, patient satisfac-
tion). Practice audits (83-86) to facilitate maintenance of competence 
should be complemented by a formal annual evaluation of endos-
copy performance. Any serious unplanned event or series of events 
should be reviewed by the endoscopist and quality assurance committee 
with documentation of deficiencies, discrepancies and any consequent 
actions. Audits can detect poor performance/inadequate numbers and 
can improve outcomes such as colonoscopy completion rate (52,87-89).
Unverified self-reporting is not encouraged as a formal perform-
ance indicator, although this does not preclude self-reflection based on 
structured practice audits directed at personal learning programs. 
Verifiable databases, generated from electronic reporting systems or 
web-based practice audits, have greater validity for documenting, but 
these do require that endoscopy facilities have tools available to mon-
itor outcomes.
Statement 18. Endoscopists should be granted privileges to per-
form specified procedures based on a formal evaluation of their 
competence consistent with appropriate current standards.
Evidence grade: Low/very low
Strength of recommendation: Do it, 100%
level of agreement with recommendation: Agree, 100% (agree 
strongly, 91%; agree moderately, 9%)
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Statement 19. Endoscopists’ privileges should be subject to for-
mal, regular, scheduled review to ensure that renewal is based on 
documented competence to perform specified procedures consist-
ent with appropriate current standards.
Evidence grade: Low/very low
Strength of recommendation: Do it, 94%; possibly do it, 3%; pos-
sibly don’t do it, 3%
level of agreement with recommendation: Agree, 97% (agree 
strongly, 89%; agree moderately, 9%; disagree slightly, 3%)
Discussion
Health care institutions are legally responsible for ensuring that indi-
viduals who perform procedures are competent (3). Endoscopy privil-
eges are granted or renewed by health care institutions, including 
hospitals and out-of-hospital endoscopy facilities, to competent indi-
viduals based on regional and national guidelines and regulations.
Policies guiding the granting of endoscopic privileges should be 
applied uniformly for all endoscopists; privileges should be granted 
separately for each endoscopic procedure, based on competence deter-
mined according to current standards (5-8). Each institution should 
specify appropriate standards, monitor adherence to standards and 
update standards, as needed.
When applying for privileges, the applicant and training program 
director must provide details of training undertaken for each endo-
scopic procedure requested. Each application should be reviewed by a 
clinician who is knowledgeable about the relevant procedure; proced-
ural competence should be documented from direct observation of the 
applicant’s performance at the privileging institution or by the training 
program director.
Endoscopic privileges should be granted for a finite period to per-
mit regular re-evaluation of the applicant’s performance and compe-
tency; procedural volumes should also be evaluated because, for 
example, colonoscopic complications have been associated with pro-
cedures performed by lower-volume endoscopists (90). Renewal of 
privileges should be based on defined policies for addressing poor 
performance.
SECtIon 5: EnDoSCoPy REPoRtInG StAnDARDS
Introduction
A completed, comprehensive endoscopy report is an essential element 
of a quality endoscopy service. Traditional, narrative reporting is asso-
ciated with marked variations in the documentation of positive find-
ings, pertinent negative findings and other procedural details. Effective 
communication of procedural findings and successful practice audit 
and quality improvement processes are virtually impossible in the 
absence of a standardized, ideally electronic, endoscopy report format.
Statement 20. Endoscopic procedures should be reported in a 
standardized electronic format, including mandatory reporting 
fields, to provide full documentation of all necessary clinical and 
quality measures.
Evidence grade: Low/very low
Strength of recommendation: Do it, 82%; possibly do it, 15%; don’t 
do it, 3%
level of agreement with recommendation: Agree, 97% (agree 
strongly, 76%; agree moderately, 15%; agree slightly, 6%; disagree 
strongly, 3%)
Discussion
Deficits in endoscopy reporting include marked variability in the def-
initions of inflammation in ulcerative colitis (91), as well as marked 
differences in the completion of different report elements such as 
lesion identification and removal (84% of reports), sedation procedure 
(75%), demographic data (69%), procedure interpretation (58%), 
patient history (57%) and procedure quality (40%) (92).
Electronic reporting offers a data collection method that can be 
more complete and cost-effective – but no more time-consuming – 
than handwritten reports or free-text dictated reports (93). Although 
electronic reporting is initially more expensive than handwritten or 
dictated reporting (94), the overall costs become comparable after five 
years, and cost-benefit outcomes are better after three years, in part, 
because automatic electronic transmission of reports reduces costs, 
administrative workload and communication delays.
Standardization of electronic reports, including mandatory 
reporting elements (Box 9) and accepted grading systems (Box 10), 
permits standardization of the data capture and long-term storage (at 
least 10 years) needed for audit and quality improvement processes. 
While electronic data (eg, digital transcripts of dictated reports) are 
preferable to handwritten reports, they are inferior to a full, structured 
electronic report.
box 9
Required endoscopy report elements
Report field 
Comment
Consensus, 
%
1. Type of procedure 100.0
	 Esophagastoduodenoscopy,	colonoscopy,	etc	
2. Date and time of procedure 100.0
3. Name of endoscopist 100.0
 Including trainee and supervisor
4. Name(s) of assistant(s) 91.4
	 Endoscopy	nurse,	respiratory	technician,	etc
5.	Age	and	sex	of	patient 100.0
6. Indication(s) for procedure 100.0
 Consistent with guidelines for appropriate indications
7. Comorbidities 91.4
 Assessed using American Society of Anesthesiologists physical 
status	classification	system	(95),	Mallampati	score	(96),	etc
8. Type of bowel preparation 91.4
 Including timing and adherence to prescribed regimen
9. Type and dose of sedation used 100.0
 Including incremental dose adjustment
10. Other medication and related information 97.2
	 Administration	route,	reversal	agents,	antispasmodics,	
allergies,	etc	
11.	Extent	and	completeness	of	examination 100.0
	 Confirmed	by	independent	observer	and/or	
photodocumentation;	withdrawal	time	(colonoscopy)	and	
retroflexion	manoeuvres
12. Quality of bowel preparation 97.2
	 Assessed	formally,	using	a	validated	tool	or	standard	scale	
(59,60)
13. Relevant findings 97.2
	 Using	relevant,	standardized	descriptions	and	validated	
scales
14. Pertinent negatives 97.2
	 Using	relevant,	standardized	descriptions	and	validated	
scales
15. Adverse events and resulting interventions 100.0
	 Using	relevant,	standardized	descriptions	and	validated	
scales
16. Patient comfort 100.0
	 Using	formal	descriptors	and,	if	possible,	a	validated	scale
17. Diagnoses 100.0
 Using standard terminology and validated scales
18. Endoscopic interventions performed 100.0
 Using standard terminology and descriptors
19. Details of pathology specimens 100.0
CAG endoscopy consensus guidelines
Can J Gastroenterol Vol 26 No 1 January 2012 27
	 Number	and	location	of	biopsies;	number,	size	and	location	
of polyps
20. Details of follow-up arrangements 97.2
 Identify person responsible for booking further tests and 
follow-up
21.	Appended	pathology	report(s),	when	available 94.3
	 Requires	reconciliation	of	endoscopy	and	pathology	reports
22. Management recommendations 100.0
	 Including	medication,	tests	and	follow-up
23.	Information	provided	to	patient	and/or	family 91.4
	 Description	of	findings;	contact	details	in	the	event	of	an	
emergency
box 10
Grading systems appropriate for electronic  
reporting forms
•	Patient	status:	American	Society	of	Anesthesiologists	physical	status	
classification	system	(95),	Mallampati	score	(96)
•	Bowel	preparation:	Boston	Bowel	Preparation	scale	(60)	or	Ottawa	Bowel	
Preparation scale (59)
•	Reflux	esophagitis	severity:	Los	Angeles	classification	(97,98)
•	Barrett’s	esophagus	diagnosis	and	extent:	Prague	C	&	M	criteria	(99)
•	Crohn’s	disease	–	SES-CD	activity	score	(100)		
•	Ulcerative	colitis	disease	activity:	Mayo	score	(101,102)
•	Bleeding	lesions	–	Forrest	classification	(103)
•	Esophageal	varices	–	grade	size	(104,105)
•	Readiness	for	discharge:	Aldrete	score	(64,65)
Statement 21. Endoscopy facilities should implement policies to 
monitor and ensure the timeliness and completeness of procedure 
reporting.
Evidence grade: Low/very low
Strength of recommendation: Do it, 100%
level of agreement with recommendation: Agree, 100% (agree 
strongly, 91%; agree moderately, 6%; agree slightly, 3%)
Discussion
An important aspect of clinicians’ competency relates to the timely 
provision of a completed procedure report. Receipt of a procedure 
report improves patients’ adherence to follow-up appointments and 
therapies (66). Optimally, the endoscopy report should be available on 
the day of the endoscopy, either as a modified, patient-centred version 
or as the formal report, supplemented by a patient-centred summary. 
When relevant, pathology results should accompany the final endos-
copy report but this can be a technical challenge because it requires 
linkage of separate databases. Patient concerns regarding their test 
results should be addressed in a timely manner although the nature 
and timeliness of the response may, legitimately, vary among institu-
tions, depending on local needs and resources.
SECtIon 6: PAtIEnt PERCEPtIonS
Introduction
Patient-centred care is predicated on a satisfactory patient experience 
in endoscopy, as in all other areas of health care delivery; thus, assess-
ments of endoscopy quality must include domains that are important 
to patients.
Statement 22. Endoscopy facilities should ensure that the services 
they provide are patient-centred.
Evidence grade: Moderate to very low
Strength of recommendation: Do it, 85%; possibly do it, 12%; don’t 
do it, 3%
level of agreement with recommendation: Agree, 100% (agree 
strongly, 71%; agree moderately, 26%; agree slightly, 3%)
Discussion
Acknowledgement of the patient’s perspective on all aspects of endos-
copy service delivery and responsiveness to their concerns necessitates 
a collaborative relationship between the clinician and the patient to 
address the quality of the patient’s experience and the appropriateness, 
accuracy and safety of the procedure. Patients’ perspectives on quality 
endoscopy care were reviewed at the consensus conference based on 
the results of focus groups held in French and English Canada for 
adults who had undergone or were scheduled to undergo a colonos-
copy. Focus group participants’ discussions of the total colonoscopy 
experience, defined as all factors and events occurring before, during 
and after the day of the procedure, yielded several major quality 
themes, including communication: quantity and quality; comfort: 
physical and psychological; and attitude and demeanor: physician and 
endoscopy unit staff. Endoscopist expertise, procedural safety and 
physical amenities were also important. Many patients expressed little 
concern about quality indicators (106-108), reporting that they 
trusted the accuracy and safety of the test on the presumption that 
tests were closely monitored and regulated to ensure adherence to 
standards.
Preprocedural educational interventions, such as provision of addi-
tional information, as an educational video (16,109), booklet (110), 
face-to-face discussion (111) or behavioural intervention (112) can 
support patients’ need to understand the procedure and improve their 
satisfaction and appointment keeping. Interventions may have a lim-
ited effect, due to high preprocedural satisfaction levels (113), but they 
can, nonetheless, improve patients’ knowledge about the procedure.
In theory, patients should be more likely to comply with follow-up 
examinations if they experienced high levels of satisfaction with their 
previous endoscopic procedure; to date however, this hypothesis 
remains unproven.
Statement 23. Endoscopy facilities should systematically and at 
least annually solicit patient feedback, report the results to the 
service and to the institution’s quality committee, and implement 
effective measures to address patients’ concerns.
Evidence grade: Very low
Strength of recommendation: Do it, 94%; possibly do it, 6%
level of agreement with recommendation: Agree, 100% (agree 
strongly, 82%; agree moderately, 15%; agree slightly, 3%)
Discussion
The increasing and appropriate emphasis on patient-centred care 
requires that patients provide feedback on their experience to inform 
endoscopy facilities’ decisions on balancing cost and volumes, access 
and wait times, discomfort and completion rates, and resources and 
procedural times. Patient feedback should be sought, at least annually 
(10), using one or more methods including satisfaction surveys, focus 
groups and invited comments. Patient feedback is essential for assess-
ing many aspects of endoscopy service delivery, such as the quality of 
the informed consent process (114), and offers measurable improve-
ments in patient experience (115). Regular, structured measurement 
of patient satisfaction ensures that patients’ perspectives are evaluated 
alongside more traditional indicators such as appropriateness, accuracy 
and safety.
ConCluSIonS
Gastrointestinal endoscopy is a complex diagnostic and therapeutic 
undertaking that demands a high level of skill and knowledge on the 
part of the operator (2,5). However, high-quality endoscopy requires 
Armstrong  et al
Can J Gastroenterol Vol 26 No 1 January 201228
more than a skilled operator – the delivery of high-quality endoscopy 
services, in a cost-effective manner consistent with the broader needs 
of a health care system, requires a formal quality improvement frame-
work that addresses all aspects of endoscopy service delivery from the 
patient’s initial contact with a health care provider (eg, the identifica-
tion of family history of colon cancer in an asymptomatic individual) 
through to documentation of long-term outcomes (eg, freedom from 
colon cancer over decades). Recognition of the patient as the focus of 
the endoscopy process provides a structure for integrating the efforts of 
the many diverse disciplines whose contribution is needed to ensure a 
high-quality service.
The fundamental principle underlying high-quality health care is 
the need for an iterative feedback loop centred on the patient’s needs.
The feedback loop requires identification of the patient’s needs, meas-
urement of the extent to which these needs are met, intervention to 
ensure that unmet needs are addressed and reassessment of the 
patient’s needs after intervention. The GRS (10) is a quality improve-
ment tool that enables the adoption of iterative quality improvement 
processes in endoscopy, supported by the identification of quality and 
safety indicators relevant to specific aspects of service delivery.
Whenever possible, health care recommendations are based on the 
highest quality evidence available. Outcomes of this consensus confer-
ence confirm that there is a paucity of high-grade evidence relevant to 
endoscopy service delivery. However, among a large multidisciplinary 
group of health care professionals, there was a high level of agreement 
on key features that should be addressed to improve endoscopy quality. 
The fact that the supporting evidence was generally graded as ‘low’ or 
‘very low’ does not indicate that the recommendations, themselves, 
are weak; it indicates, rather, the need for concerted, widespread 
efforts to document the short- and long-term effects of adopting new 
quality improvement processes in endoscopy.
The consensus process, presented in the current report, provides 
the framework for a quality improvement structure in endoscopy based 
on explicit recommendations that will support systematic monitoring, 
assessment and modifications in endoscopy service delivery; this 
framework is intended to yield benefits for all patients whose care may 
be affected by the practice of gastrointestinal endoscopy.
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